FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 9, 2005
Table of Contents
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
2004N-0081 BSE Risk Materials in Foods and Cosmetics
2004N-0355 Scientific Considerations Related to Developing Follow-on Protein Products
2004P-0334 Submit Validation Data for Reprocessed Single-Use Electrosurgical Cutting and Coagulation Devices and Accessories
2005D-0344 Class II Special Controls Guidance Document: Tinnitus Masker Devices
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 16803 Life Plus International Vol #: 151
LET 16804 RKS Inc. Vol #: 151
LET 16805 Garden of Life, Inc. Vol #: 151
LET 16806 Anabolic Laboratories,Inc. Vol #: 151
LET 16807 Anabolic Laboratories, Inc. Vol #: 151
LET 16808 Anabolic Laboratories, Inc. Vol #: 151
LET 16809 Anabolic Laboratories, Inc. Vol #: 151
LET 16810 Anabolic Laboratories, Inc. Vol #: 151
LET 16811 Anabolic Laboratories, Inc. Vol #: 151
LET 16812 Anabolic Laboratories, Inc. Vol #: 151
LET 16813 Natreon, Inc. Vol #: 151
LET 16814 McLind Corporation Vol #: 151
LET 16815 Fitness labs Nutrition Corporation Vol #: 151
LET 16816 Fitness Labs Nutrition Corporation Vol #: 151
LET 16817 Fitness Labs Nutrition Corporation Vol #: 151
LET 16818 Fitness Labs Nutrition Corporation Vol #: 151
LET 16819 Fitness Labs Nutrition Corporation Vol #: 151
LET 16820 Fitness Nutrition Corporation Vol #: 151
LET 16821 Perrigo Company of South Carolina Vol #: 151
LET 16822 Perrigo Company of South Carolina Vol #: 151
LET 16823 Perrigo Company of South Carolina Vol #: 152
LET 16824 W.F. Young, Inc. Vol #: 152
LET 16825 W.F. Young, Inc. Vol #: 152
LET 16826 AdvoCare International, L.P. Vol #: 152
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
LET 843 HFS-800 to HerbsForever, Inc Vol #: 25
LET 844 HFS-800 to CanPrev LLC Vol #: 25
LET 845 HFS-800 to New Chapter Inc Vol #: 25
LET 846 HFS-800 to Creative Enterprises Inc Vol #: 25
LET 847 HFS-800 to Apex Fitness Group Vol #: 25
LET 848 HFS-800 to USA CTT Co. Inc Vol #: 25
LET 849 HFS-800 to Prometheon Labs LLC Vol #: 25
LET 850 HFS-800 to RKS Inc Vol #: 25
2004N-0081 BSE Risk Materials in Foods and Cosmetics
C 151 Nitta Casings, Inc. (NCI) Vol #: 13
C 152 Cosmetic, Toiletry, and Fragrance Association (CTFA) Vol #: 13
2004N-0355 Scientific Considerations Related to Developing Follow-on Protein Products
C 19 GlaxoSmithKline (GSK) Vol #: 5
2004P-0334 Submit Validation Data for Reprocessed Single-Use Electrosurgical Cutting and Coagulation Devices and Accessories
ANS 1 HFZ-001 to Hyman, Phelps & McNamara, PC Vol #: 1
2005D-0344 Class II Special Controls Guidance Document: Tinnitus Masker Devices
NAD 1 FDA Vol #: 1
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
C 478 D. Federici Vol #: 165
C 479 Planned Parenthood of the Inland Northwest Vol #: 165
C 480 S. Middleton Vol #: 165
C 481 Sister P. Miriam, MSBT Vol #: 165
C 482 L. Rodgers Vol #: 165
C 483 E. Gallagher Vol #: 165
C 484 P. McGrath Vol #: 165
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
APE 10 Feinberg School of Medicine, Northwestern University Vol #: 1
APE 11 A Liversidge Vol #: 1
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
C 43 Montgomery Anesthesia Associates, P.C. Vol #: 13
C 44 Montgomery Anesthesia Associates, P.C. Vol #: 13
C 45 Montgomery Anesthesia Associates, P.C. Vol #: 13
C 46 R. Mulner, M.D. Vol #: 13
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 3 National Association of Nurse Practitioners in Women's Health (NPWH) Vol #: 1
C 4 American Medical Women's Association (AMWA) Vol #: 1

Page created on November 18, 2005 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management